(FILES) A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel on September 9, 2025. The Swiss pharmaceutical giant Novartis on July 21, 2026 reported a 19% drop in net profit for the second quarter, to $3.2 billion (3.2 billion), held back by higher interest and tax expenses. (Photo by Fabrice COFFRINI / AFP via Getty Images)